Low
₹65.00
High
₹67.70
| Previous Close | ₹65.56 |
|---|---|
| Day's Range | ₹65.00 - ₹67.70 |
| Open | ₹67.70 |
| 52 Week Range | ₹57.50 - ₹159.00 |
| Volume | 2,582 |
| Market Cap | ₹0.00 |
| Previous Close | ₹66.10 |
|---|---|
| Day's Range | ₹64.02 - ₹66.10 |
| Open | ₹64.02 |
| 52 Week Range | ₹60.00 - ₹158.85 |
| Volume | 310 |
| Market Cap | ₹0.00 |
| Trade Value ( ₹ in Lacs) | 1.72 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 26.18 |
| TTM EPS (₹) | 2.53 |
| P/E Ratio | 12.22 |
| Book Value(₹) | 0.00 |
| PAT Margin (%) | 10.11 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 15.46 |
| Trade Value ( ₹ in Lacs) | 0.20 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 26.18 |
| TTM EPS (₹) | 2.53 |
| P/E Ratio | 12.22 |
| Book Value(₹) | 0.00 |
| PAT Margin (%) | 10.11 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 15.46 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 308.47 | 1038.38 |
| Expenses | N/A | N/A |
| PBT | 35.59 | 165.3 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 34.52 | 162.67 |
| Founded | 2004 |
|---|---|
| Managing Director | Jagdish Ajudia |
| NSE Symbol | INDOUS |
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Tata Consumer Products Ltd. | 1,06,788.48 | 1,079.00 | 916.00 - 916.00 |
| Balrampur Chini Mills Ltd. | 13,875.24 | 657.80 | 393.55 - 393.55 |
| CCL Products (India) Ltd. | 13,043.67 | 977.50 | 885.70 - 885.70 |
| E.I.D. - Parry (India) Ltd. | 11,657.88 | 655.10 | 594.35 - 594.35 |
| Gujarat Ambuja Exports Ltd. | 6,733.29 | 146.75 | 102.05 - 102.05 |
| Triveni Engineering & Industries Ltd. | 5,542.13 | 252.60 | 220.05 - 220.05 |
| Bajaj Hindusthan Sugar Ltd. | 4,389.26 | 18.36 | 14.85 - 14.85 |
| Dalmia Bharat Sugar And Industries Ltd. | 3,953.48 | 491.75 | 261.40 - 261.40 |
| Shree Renuka Sugars Ltd. | 3,937.71 | 18.50 | 17.14 - 17.14 |
| Bannari Amman Sugars Ltd. | 3,907.37 | 3,116.00 | 3,061.30 - 3,061.30 |
No Records Found
Indo Us Bio Tech has submitted the Newspaper Advertisement relating to the Unaudited quarterly & half yearly Standalone Financial Results for the quarter & Half year ended on 30th September, 2026 published in Western times - English and Western times - Gujarati Newspaper to comply Regulation 47 of SEBI LODR Regulations.
The above information is a part of company’s filings submitted to BSE.
Indo US Bio Tech has informed that the board met today, discussed and resolved following agendas: 1) Calling of Annual General Meeting (AGM) on Wednesday, 30th Day of September, 2026 at 02:30 PM through video conferencing (VC)/other Audio-Visual Means (OAVM) for the financial year ended on 31st March, 2026. 2) Approved the draft notice for calling 22nd Annual General Meeting. 3) Approved the draft of Directors’ Report for the financial year ended on 31st March, 2026. 4) Book Closure Date for the 22nd Annual General Meeting for F.Y. 2025-26 (Details as Annex A) 5) The e-voting period shall commence from Sunday, 27th September, 2026, 9:00 AM to Tuesday, 29th September, 2026, 5:00 PM. The remote e-voting module shall be disabled by NSDL after 5.00 PM on Tuesday, 29th September, 2026. The cut-off for determining the eligibility to vote is 23rd September, 2026 and only the persons holding shares of the Company (in physical or dematerialised form) on the cut-off date shall be entitled to avail the facility of remote e-voting and electronic voting through electronic Method at the Annual General Meeting (AGM) held through VC/ OAVM on 30th September, 2026. 6) Annual Report to be circulated to the Members of the Company (being Uploaded as Separate Attachment/ File) 7) Appointment of Bhagat & Associates, Chartered Accountants (FRN: 101100W) as a Statutory Auditors of the Company for a period of five consecutive years from the conclusion of the ensuing 22nd Annual General Meeting until the conclusion of the 27th Annual General Meeting, subject to the approval of the Members at the ensuing Annual General Meeting. After due consideration, the Board approved and recommended the appointment of Bhagat & Associates as the Statutory Auditors of the Company for consideration and approval of the Members at the ensuing 22nd Annual General Meeting. 8) Appoint Amrish Gandhi & Associates, Practising Company Secretary scrutinizer to scrutinize the e-voting process in a fair and transparent manner for the Annual General Meeting of the Company for the financial year ended on 31st March, 2026. 9) Any other business with the permission of the Board Chair. The Meeting commenced at 14:10 Hrs and concluded at 14:40 Hrs.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Yashhtej Industries (India) has informed that the Board of Directors of the Company in their meeting held on Friday, November 13, 2026, at the Registered Office of the Company situated at Plot No. D-73/1, Additional MIDC, Latur-413512, Maharashtra, India, has transacted the following main business: 1) Considered and approved the Unaudited Standalone Financial Results for the Half Year ended September 30, 2026, along with the Statement of Assets and Liabilities and Cash Flow Statement for the Half Year ended September 30, 2026; A copy of the Financial Results along with the Auditor’s Limited Review Report is enclosed as Annexure-A. 2). Approved the appointment of Krupa Mayankkumar Gandhi (Membership No. A82371) as the Company Secretary and Compliance Officer of the Company with effect from November 13, 2026. The details as required under Regulation 30 read with SEBI Master Circular HO/49/14/14(7)2025-CFDPOD2/1/3762/2026 dated January 30, 2026 is enclosed as Annexure-B. The Board Meeting commenced at 12:15 PM and concluded at 3:00 PM.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Zuari Industries informed that it enclosed copies of the newspaper publications, as published today, 13th November 2026 in Business Standard (All India editions, English except Ahmedabad, where the publication is scheduled for 14th November 2026 and Lokmat (Regional newspaper), for the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September 2026.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The current share price of Indo US Bio-Tech Ltd. is ₹65.56 as of 2026-11-13.
The market capitalisation of Indo US Bio-Tech Ltd. is ₹132.54 as of 2026-11-13.
The 1-year return of Indo US Bio-Tech Ltd. is -64.82% as of 2026-11-13.
The P/E ratio of Indo US Bio-Tech Ltd. is 14.96 as of 2026-11-14.
The 52-week high and low of Indo US Bio-Tech Ltd. are ₹159.00 and ₹57.50, respectively, as of 2026-11-13.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.